Merck (MRK) Inventory Average (2009 - 2026)

Merck (MRK) reported Inventory Average of $6.6 billion for Q1 2026, up 6.76% year-over-year from $6.2 billion in Q1 2025, and little changed quarter-over-quarter from $6.6 billion in Q4 2025.

Merck (MRK) Inventory Average (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Inventory Average data on file, last reported at $6.6 billion in Q1 2026.

  • Inventory Average for Q1 2026 came in at $6.6 billion, up 6.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 billion (up 6.76% YoY), and the FY2025 annual result was $6.4 billion, up 2.41% from the prior year.
  • Inventory Average steadied at $6.6 billion in Q1 2026 per MRK's latest filing, from $6.6 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $6.6 billion in Q1 2026 and troughed at $5.6 billion in Q3 2022.
  • A 5-year average of $6.2 billion and a median of $6.2 billion in 2024 frame the typical range for Inventory Average.
  • The sharpest annual moves came in 2022 and 2024: Inventory Average fell 4.97% in 2022, then increased 10.06% in 2024.
  • A 5-year view of Inventory Average shows it stood at $5.8 billion in 2022, then advanced by 8.36% to $6.2 billion in 2023, then fell by 1.09% to $6.2 billion in 2024, then rose by 6.06% to $6.6 billion in 2025, then climbed by 0.27% to $6.6 billion in 2026.
  • Business Quant data shows MRK's Inventory Average at $6.6 billion in Q1 2026, $6.6 billion in Q4 2025, and $6.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 8.09 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 14.14 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 14.39 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 5.00 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 6.57 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 6.21 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 1.84 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 10.66 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 2.72 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.57 Bn
Dec 31, 2025 6.55 Bn
Sep 30, 2025 6.52 Bn
Jun 30, 2025 6.40 Bn
Mar 31, 2025 6.15 Bn
Dec 31, 2024 6.18 Bn
Sep 30, 2024 6.36 Bn
Jun 30, 2024 6.49 Bn
Mar 31, 2024 6.43 Bn
Dec 31, 2023 6.24 Bn
Sep 30, 2023 6.03 Bn
Jun 30, 2023 5.90 Bn
Mar 31, 2023 5.89 Bn
Dec 31, 2022 5.76 Bn
Sep 30, 2022 5.57 Bn
Jun 30, 2022 5.65 Bn
Mar 31, 2022 5.86 Bn
Dec 31, 2021 5.78 Bn
Sep 30, 2021 5.55 Bn
Jun 30, 2021 5.95 Bn